Decompensated Heart Failure: Clinical Trials

2 trials for Decompensated Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Unknown 1
Phase 21Unknown 1

Follow Decompensated Heart Failure: new trials by email Literature Review of Decompensated Heart Failure trials Research Report on Decompensated Heart Failure

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Vericiguat tablet, Sacubitril / Valsartan - Decompensated Heart Failure
Phase 1RecruitingKhawaja Danish Ali1302026-01-012026-03-02
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
ivabradine, Placebo - Decompensated Heart Failure
Phase 1 / Phase 2UnknownUniversity of Sao Paulo502013-05-012017-01-02

Narrower conditions

Heart Failure (2)  ·  Emergencies (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Ivabradine (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)  ·  vericiguat (1)

Sponsors

Khawaja Danish Ali (1)  ·  University of Sao Paulo (1)

Countries

Brazil (1)  ·  Pakistan (1)

Top investigators

Edimar A Bocchi, MD-PHD (1)

Results publications

PMID 27469019